Business SK bioscience expands influenza vaccine exports to Southern Hemisphere market
By Diplomacy Journal Lee Kap-soo SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced on March 12 that the company has begun shipping its self-developed influenza vaccine, SKYCellflu, from its vaccine manufacturing facility L HOUSE to Southern Hemisphere markets, including Southeast Asia and Latin America. A total of 750,000 doses will be supplied in the first half of the year. This shipment marks the company’s second export of influenza vaccines for Southern Hemisphere use, following its initial export to Thailan